Physician profile
Alan E Colman
NPI 1487668687
$1,985.84
in general payments reported to CMS, 2019-2025
5 companies · $49.24 in 2025
The $49.24 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $137 · 2023: $1,499 · 2024: $150 · 2025: $49.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $840 · Food and Beverage: $682 · Education: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $840.06 |
| Food and Beverage | $681.58 |
| Education | $177.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,266.58 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $279.69 | 2021-2023 | Proclaim |
| Tersera Therapeutics LLC | $177.00 | 2023 | Prialt |
| Averitas Pharma INC. | $150.00 | 2024 | Qutenza |
| Bioventus LLC | $112.57 | 2023 | Stimrouter Implantable Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Colman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.